NCT06533826
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06533826
Title TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd (TRADE DXd)
Acronym TRADE DXd
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ana C Garrido-Castro, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama RECRUITING Birmingham Alabama 35294 United States Details
University of San Francisco RECRUITING San Francisco California 94158 United States Details
Yale University Cancer Center RECRUITING New Haven Connecticut 06520 United States Details
Georgetown University Medical Center RECRUITING Washington D.C. District of Columbia 20007 United States Details
University of Chicago Medical Center RECRUITING Chicago Illinois 60637 United States Details
Beth Israel Deaconess Medical Center RECRUITING Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Montefiore Einstein Comprehensive Cancer Center RECRUITING The Bronx New York 10461 United States Details
University of North Carolina RECRUITING Chapel Hill North Carolina 27599 United States Details
Vanderbilt Cancer Center RECRUITING Nashville Tennessee 37232 United States Details
Baylor College of Medicine RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field